📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. (2021)

First Author: Whiley L

Attributed to: Establishing MRC-NIHR Phenome Centre, a world leading high-throughput metabolic phenotyping centre for humanpopulation disease-risk biomarker discovery. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.63075

Publication URI: https://www.repository.cam.ac.uk/handle/1810/315965

Type: Journal Article/Review